IMARC Group, a leading market research company, has recently releases report titled “Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global cancer cachexia market share.
How Big Is the Cancer Cachexia Market?
The global cancer cachexia market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.
Factors Affecting the Growth of the Global Cancer Cachexia Industry:
- Increasing Prevalence of Cancer:
The rising incidence of cancer is resulting in the expansion of the cancer cachexia market. Cancer cachexia is a multifaceted syndrome that severely impacts patients, manifesting through involuntary weight loss, muscle wasting, profound fatigue, and an overarching decline in physiological function which can occur in the early stages, affecting treatment outcomes and patient quality of life. Moreover, the rising cancer cases can be attributed to various factors, including growing geriatric populations, lifestyle changes, environmental exposures, and genetic predispositions which requires parallel increase in effective management strategies for cancer cachexia. Besides this, the rising demand for comprehensive treatment approaches that includes nutritional support, pharmacological interventions, and physical therapy is contributing to the market growth.
- Growing Awareness and Understanding:
The increase in awareness and understanding of cancer cachexia among healthcare professionals and patients is influencing the market growth. In addition, the growing recognition of the importance of holistic patient care includes managing the complex symptoms of cachexia to improve patient outcomes and quality of life. Moreover, healthcare professionals are now more informed about the signs and implications of cancer cachexia, leading to earlier identification and intervention. Along with this, the growing awareness is escalating the demand for specialized treatments that target the multifaceted aspects of cachexia, including metabolic imbalances, inflammation, and nutritional deficiencies. There is an emphasis on multidisciplinary care models that integrate dietary counseling, pharmacological treatments, and physical therapy to mitigate the impact of cachexia.
- Advancements in Cancer Care:
The market is driven by advancements in early detection, targeted therapies, and the personalization of treatment plans. These developments are extending survival rates and improving the quality of life for many cancer patients, which is increasing the need to address the comprehensive well-being of patients, including the management of cancer cachexia. Moreover, early detection and targeted therapies offer a more precise approach to treating cancer, focusing on the molecular and genetic underpinnings of the disease which allows for treatments that are more effective and have fewer side effects, contributing to better overall patient outcomes. Furthermore, personalized medicine tailors’ treatment to the individual characteristics of each patient and their cancer, further enhancing the effectiveness of cancer care.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cancer-cachexia-market/requestsample
Leading Companies Operating in the Global Cancer Cachexia Industry:
- AAVogen Inc.
- Actimed Therapeutics Ltd.
- Aphios Corporation
- Artelo Biosciences Inc.
- AVEO Pharmaceuticals Inc.
- Fresenius Kabi AG (Fresenius SE & Co. KGaA)
- Helsinn Healthcare SA
- Merck & Co. Inc.
- NGM Biopharmaceuticals Inc.
- Pfizer Inc.
- Tetra Bio-Pharma
Cancer Cachexia Market Report Segmentation:
By Therapeutics:
- Progestogens
- Corticosteroids
- Combination Therapy
- Others
Progestogens account for the largest market share due to their effectiveness in stimulating appetite and promoting weight gain in patients.
By Mode of Action:
- Appetite Stimulators
- Weight Loss Stabilizers
Weight loss stabilizers dominate the market growth due to the essential role in managing the metabolic imbalances associated with cancer cachexia, helping to stabilize patients’ weight.
By Distribution Channel:
- Hospital Stores
- Retail Pharmacy
- Online Pharmacy
By distribution channel, the market is classified into hospital stores, retail pharmacy, and online pharmacy.
Regional Insight:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America’s market growth is attributed to the advanced healthcare infrastructure of the region, increasing prevalence of cancer, and the presence of leading pharmaceutical companies investing in cachexia research and drug development.
Global Cancer Cachexia Market Trends:
At present, the increasing R&D activities by pharmaceutical and biotech companies to develop effective treatments for cancer cachexia focuses on novel therapeutic agents and combinations that target multiple pathways involved in cachexia syndrome. Besides this, the changing shift toward the adoption of multimodal treatment strategies that combine nutritional support, pharmacological interventions, and physical exercise to address the complex nature of cancer cachexia is contributing to the market growth.
Along with this, strategic partnerships between academia, industry, and research organizations are vital in advancing research, sharing knowledge, and accelerating the development of effective cachexia treatments. Furthermore, the extensive use of digital health technologies, including telemedicine and wearable devices for monitoring cachexia patients’ nutritional status, physical activity, and overall health are facilitating personalized and remote patient care.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
